Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Booms, Busts, and Recoveries -- Ignore unavailable to you. Want to Upgrade?

To: shades who wrote (65848)	7/3/2005 4:28:00 AM
From: elmatador	Read Replies (1) \| Respond to of 74559

Threaten send both home in the next flight if they don't stop winning. That quiet them down for a while. My bathroom is full with half dozen types of shampoos. They refuse to walk on the blazing sun even thought weather in Curitiba is misereable now and they should be glad to be out of it.

To: shades who wrote (65848)	7/3/2005 5:03:46 AM
From: energyplay	Read Replies (1) \| Respond to of 74559

Ecstacy and some drugs in that class has the nasty habit of overstimulaing dopamine producion to a point where the actual production capability is impaired, sometimes producing Parkinson's type symptoms in a small number of doses, possible as low a one. For some people, the symptons don't go away. The potential for psychological instability and damage is high, probaly higher than amphetimines and maybe as high as cocaine. Some of the byproducts of amature attempts at ecstacy production are worse. On the bright side, a victim of ecstacy and MDMA had symptons of Parkinson's, and this lead to much better understanding of that disease. Saved a bunch of lab rats too.